Research funder · United States
Melanoma Research Alliance
Nonprofit organization in Washington D.C., United States
- Grants since 2016
- 400
- Awarded, last 5 years (where amounts are published)
- 72.1M
- Funded works, last 5 years
- 1 190
- Funded works, all time
- 2 826
Grants
2023–2026 · award
Dissecting melanoma brain metastasis and response to immunotherapy
Eva Perez-Guijarro · Spanish National Cancer Research Centre
2023–2026 · award
Image-Based Three-Dimensional Radiation Dosimetry for Ac-225-MTI-201
Chris Tichacek · Moffitt Cancer Center
2023–2026 · award
Genetic mechanisms early melanoma progression
Adam Dupuy · University of Iowa
2023–2026 · award
Therapeutic targeting of Hdm2/HdmX E3 ligase in melanoma
Julio Camarero · Regent University
2023–2026 · award
Memory T cell Responses in Primary Melanoma
Christina Angeles · Regent University
2023–2026 · award
Mechanisms underlying the oncogenic role of ORAI2 in melanoma
Stefan Feske · New York University
2023–2025 · award
Armoring CD8+ T cells against energetic deficiency in melanoma
Timothy Bullock · University of Virginia
2023–2024 · award
The role of APOE isoforms in the hereditary basis of rare melanomas
Neil Neumann · Rockefeller University
2023–2026 · award
Monitoring early response to immunotherapy with ultrasensitive plasma WGS
Adam Widman · Memorial Sloan Kettering Cancer Center
2023–2026 · award
Precision, plasma-only, melanoma ctDNA residual disease monitoring
Dan Landau · Cornell University
2023–2024 · award
EN2 and HOXD13 are two novel melanoma-specific transcription factors
Pietro Berico · New York University
2023–2026 · award
Tumor immune evasion through STING-mediated T cell death in melanoma
Jianjun Wu · Cleveland Clinic Lerner College of Medicine
2023–2025 · award
Targeting ASAP1-induced transcription factors in metastatic uveal melanoma
Shannon Odelberg · University of Utah
2023–2028 · award
Advancing Memory Like Natural Killer Cells for Metastatic Melanoma
Todd Fehniger · Washington University in St. Louis
2023–2026 · award
Dissecting the dynamic immune ecosystem during melanoma evolution
Diego Chowell · Icahn School of Medicine at Mount Sinai
2023–2026 · award
Bioengineering approaches for advancing targeted-immunotherapy in melanoma
Tanmoy Saha · Brigham and Women's Hospital
2023–2026 · award
Resolving the spatial clonal architecture of acral lentiginous melanoma
Meng Wang · Regent University
2023–2024 · award
Micronuclear rupture and DNA damage in primary cutaneous melanoma prognosis
Xiao Zhang · The Regents Of The University Of California, Los Angeles
2023–2026 · award
Sustaining metabolic fitness of antitumor CD8+ T cells
Bin Zhang · Northwestern University
2023–2025 · award
Identifying genetic sex biasing factors in melanoma progression
Nora Engel · Fox Chase Cancer Center
2023–2025 · award
A drug-binding assay platform to optimize therapies for RAS-mut melanomas
Poulikos Poulikakos · Icahn School of Medicine at Mount Sinai
2023–2025 · award
Epigenetic determinants of melanoma progression and immunotherapy response
Alfonso Bellacosa · Fox Chase Cancer Center
2023–2026 · award
Catabolic plasticity in acral melanoma metastases and drug tolerance
Vito Rebecca · Johns Hopkins University Applied Physics Laboratory
2023–2024 · award
Epigenetics and Acral Melanoma Prognostic Model for Skin of Color Patients
Simon F. Roy · Yale University
2023–2025 · award
The CoREST Repressor Complex as a Mediator of RNA Splicing and Tumor Growth
Rhoda Alani · Trustees Of Boston University
2023–2026 · award
Vaccine-tunable TME-restricted CAR T therapy for long-term melanoma control
Leyuan Ma · The Wistar Institute
2023–2026 · award
Dissecting the mechanisms of melanoma cell adaptation to the brain
Eva Hernando · New York University
2023–2026 · award
Multi-modal machine learning for early-stage melanoma recurrence prediction
Yevgeniy Semenov · Harvard University
2022–2025 · award
Identification & Validation of Novel Druggable Targets in Mucosal Melanoma
Genevieve Boland · Johns Hopkins University Applied Physics Laboratory
2022–2023 · award
Validation of the Melanoma Risk Evaluation (MRE)
Steven Caleb Freeman · Huntsman Cancer Institute
2022–2023 · award
Alcohol metabolism in human melanocytes
Takeshi Yamauchi · University of Colorado Anschutz
2022–2025 · award
Interfering with early cell state transitions to prevent drug tolerance
Florian Rambow · Stiftung Universitätsmedizin Essen
2022–2025 · award
Noninvasive prediction of severe toxicity from immune checkpoint blockade
Mario Sznol · Stanford University
2022–2025 · award
mRNA-based re-programming of terminally differentiated TILs
Yochai Wolf · The Sheba Fund For Health Service And Research
2022–2024 · award
Investigating ARID2 as a suppressor of melanoma metastasis
Emily Bernstein · New York University
2022–2023 · award
Individualized Melanoma Prediction Using Self-Adaptive Machine Learning
Guihong Wan · Massachusetts General Hospital
2022–2025 · award
Investigating the role of FGL1/LAG-3 axis in melanoma immunity
Jun Wang · New York University
2022–2023 · award
Genomic instability in melanomagenesis and progression
Prashanthi Dharanipragada · The Regents Of The University Of California, Los Angeles
2022–2025 · award
Improving immunological memory during anti-PD-1 immunotherapy
Arlene Sharpe · Dana-Farber Cancer Institute
2022–2025 · award
Cellular Barcoding to Define Melanoma Drug Resistance and Cell of Origin
E. Elizabeth Patton · Dana-Farber Cancer Institute